Search
for
Sort by
Research 841–870 of 1000+
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Drug-Induced Skin, Nail and Hair Disorders
- A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- Androgen Dependence of Hirsutism, Acne, and Alopecia in Women
- Association between Smoking and Hair Loss: Another Opportunity for Health Education against Smoking?
- Androgens and androgen receptor action in skin and hair follicles
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1
- The effect of metformin on hirsutism in polycystic ovary syndrome
- Dermatologic manifestations of endocrine disorders
- Depression, anxiety and perceived stress in women with and without PCOS: a community-based study
- Clinical and biological impact of the exposome on the skin
- Clinical Aspects and Spectrum of Illness of TSS: Overview
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Physiological and biological skin changes in pregnancy
- Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Telogen effluvium
- Approach to the adult female patient with diffuse nonscarring alopecia
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome
- DRUG‐ASSOCIATED ALOPECIA
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- Female Pattern Hair Loss